Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rochelle Robicheaux Metoyer (NPI 1750575890)

Field	Value
Entity Type	Individual
Organization	Rochelle Robicheaux Metoyer
Address	1200 S Farmerville St
City	Ruston
State	LA
ZIP	71270
Taxonomy	Rheumatology Physician
NPI Enumerated	August 31, 2007

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer Medicare: lifetime Medicare revenue is $2.9M and there is no Medicaid billing on file (listed as none). The lack of any Medicaid activity suggests the practice’s revenue and patient mix are concentrated in the Medicare population rather than split across both programs.

Revenue is highly concentrated in a small set of drug administration codes: the precomputed top‑3 Medicare codes account for 69.4% of total Medicare revenue, with J0129 alone generating $1.4M (48.5% of Medicare revenue). J9312 contributes $323.2K (11.2%) and J1602 contributes $280.2K (9.7%), indicating very large dependence on a few high‑value injectable biologics.

The code mix points to an infusion‑centric rheumatology practice that administers biologic agents and provides high‑complexity office care. High revenue from J0129, J9312, J1602, plus substantial entries for J1745, Q5104, Q5115 and infusion/administration codes such as 96365 and 96413, indicate the operation includes on‑site IV biologic infusion and chemotherapy/infusion administration capacity.

The provider’s competitive standing is extreme for specific items: J0129 is reported at rank #9 of 1221 providers nationally (99th percentile; extreme outlier), and the E/M code 99215 is ranked #111 of 145531 (100th percentile; extreme outlier). These ranks place the clinician well above typical national volume for abatacept administration and for high‑complexity office visits compared with peers.

In addition to the single‑drug outlier, several infusion/administration codes show above‑typical throughput: 96415 ranks #43 of 4959 (99th percentile; extreme outlier), 96365 ranks #239 of 8873 (97th percentile; notably above typical), and 96413 ranks #537 of 7514 (93th percentile; notably above typical). Together these patterns reinforce that the practice runs a higher‑volume infusion/chemotherapy administration service than most national peers.

The provider is an established practitioner with a long tenure: NPI enumerated 2007-08-31 (~19 years ago). This length of enrollment is consistent with a stable referral base and the ability to sustain a specialized infusion service over time.

The provider displays an active mix of branded biologics and biosimilars in its portfolio, with notable billing for biosimilars like Q5104 ($140.8K) and Q5115 ($125.5K) alongside originator products such as J1745 ($113.1K). Ranks for these biosimilar codes (for example, Q5104 at #21 of 178, 89th percentile) show engagement with biosimilar options at levels above many peers, suggesting procurement or formulary strategies that include both originators and biosimilars.

The heavy reliance on a few high‑revenue injectable codes (top 3 = 69.4% of Medicare revenue) implies revenue sensitivity to changes in drug pricing, utilization, or reimbursement policy. Because nearly half of Medicare revenue comes from J0129 alone ($1.4M, 48.5%), shifts in coverage or payer mix for that specific agent would materially affect overall revenue performance.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	43,650	$30	$1.4M
J9312	Injection, rituximab, 10 mg	5,050	$60	$323.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	28,020	$10	$280.2K
J0897	Injection, denosumab, 1 mg	9,120	$20	$164.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	1,280	$120	$156K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	5,030	$30	$140.8K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	3,800	$30	$125.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	4,350	$30	$113.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	550	$80	$45.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	390	$80	$32.2K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Rochelle Robicheaux Metoyer — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1602	7	10	26,920	$10	$526.5K
J0129	1	10	9,490	$30	$506.1K
J9312	1	10	3,770	$60	$233.2K
Q5115	1	10	3,800	$30	$125.6K
J0897	12	70	3,120	$20	$105.6K
Q5104	1	10	2,600	$30	$95.4K
J1745	2	10	3,110	$30	$80K
Q5103	1	10	1,600	$20	$28.1K
96413	8	70	140	$90	$22.8K
99214	1,028	6,670	110	$80	$16.5K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rochelle Robicheaux Metoyer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Green Clinic LLC	LA	Family Medicine Physician	$0	$9.5M
James Keane	AR	Procedural Dermatology Physician	$4.9M	$0
Harshivinderjit Bains	TX	Ophthalmology Physician	$4.1M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Amar Patel	TX	Ophthalmology Physician	$3.8M	$0
Thomas Bochow	TX	Ophthalmology Physician	$3.6M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Jyothi Mallepalli	LA	Rheumatology Physician	$3.2M	$0
Kirtan Koticha	LA	Hematology & Oncology Physician	$3.1M	$0
Jonathan Tzu	TX	Ophthalmology Physician	$2.8M	$0

Nearby Providers

Other providers in the same ZIP code as Rochelle Robicheaux Metoyer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Louisiana United Methodist Children & Family Services, Inc	LA	Psychiatric Residential Treatment Facility	$0	$99.5M
Lincoln Nova Vital Recovery Center,llc	LA	Substance Abuse Rehabilitation Facility	$0	$36.8M
Pafford Emergency Medical Services, Inc.	LA	Ambulance	$4.6M	$23.2M
People Centered Support Services, Inc.	LA	Community/Behavioral Health Agency	$0	$14.4M
Certicare, Inc	LA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$9.8M
Peach Tree For Kids - Ruston, LLC	LA	Pediatric Dentistry	$0	$9M
Little Helper's, LLC	LA	Health Maintenance Organization	$0	$7.8M
Winn Community Health Center, Inc.	LA	Federally Qualified Health Center (FQHC)	$0	$7.3M
Clhg-ruston LLC	LA	General Acute Care Hospital	$0	$5.5M
Community Bridges West, Inc.	LA	In Home Supportive Care Agency	$0	$4.7M

Rochelle Robicheaux Metoyer — Billing Profile & Reimbursement Data

Sign up for Rochelle Robicheaux Metoyer — Billing Profile & Reimbursement Data policy alerts

Rochelle Robicheaux Metoyer — Billing Profile & Reimbursement Data

Sign up for Rochelle Robicheaux Metoyer — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References